Altamira Therapeutics (@AltamiraTx) header
Altamira Therapeutics (@AltamiraTx) profile picture

We are addressing unmet medical needs with focus on RNA therapeutics, allergies, viral infections & inner ear disorders. $CYTO

Joined April 2022
Photo by Altamira Therapeutics (@AltamiraTx)Photo by Altamira Therapeutics (@AltamiraTx)Photo by Altamira Therapeutics (@AltamiraTx)Photo by Altamira Therapeutics (@AltamiraTx)Photo by Altamira Therapeutics (@AltamiraTx)Photo by Altamira Therapeutics (@AltamiraTx)Photo by Altamira Therapeutics (@AltamiraTx)Photo by Altamira Therapeutics (@AltamiraTx)Photo by Altamira Therapeutics (@AltamiraTx)Photo by Altamira Therapeutics (@AltamiraTx)
Altamira Therapeutics to Present at Formulation and Delivery Europe Conference Altamira Therapeutics has news to share!
19
Altamira Therapeutics has news to share! altamiratx.com/news
35
Altamira Therapeutics has news to share! Altamira Announces Publication Highlighting Potential of RNA Nanoparticles for Disease-Modifying Treatment of Osteoarthritis
1
46
Altamira Therapeutics Announces Collaboration on Circular RNA Delivery globenewswire.com/NewsRoom/R…
45
Altamira Therapeutics Provides Business Update, Reports Full Year 2024 Financial Results globenewswire.com/NewsRoom/R…
42
Altamira Therapeutics to Host Full Year 2024 Financial Results and Business Update Call on April 30, 2025 globenewswire.com/NewsRoom/R…
42
Altamira Announces Notice of Allowance from USPTO for Bentrio Nasal Spray Patent Great news - first patent granted! One step closer to bringing Bentrio to US allergy sufferers. globenewswire.com/NewsRoom/R…
51
Altamira Therapeutics Announces Collaboration on Radiopharmaceutical Targeting Strategies globenewswire.com/NewsRoom/R…
63
Altamira Therapeutics Announces Extension of Bentrio Distribution Agreement with Pharma Nordic to Include Sweden and Denmark. lnkd.in/eKtC-AWB
1
2
1
190
Altamira Therapeutics Announces Confirmed Suitability of Bentrio for Athletes as Comprehensive Testing Shows Absence of Prohibited Substances.
1
1
285
Altamira Therapeutics Announces Significant Enhancement of Immune Checkpoint Inhibition Therapy in Combination with Zbtb46 mRNA Delivered with SemaPhore Nanoparticles in Animal Tumor Models bit.ly/46Jej2Y
1
1
309
Altamira Therapeutics Highlights Newly Published Review Article Supporting Use of Betahistine in Vertigo Management bit.ly/3VRbBV6
1
144
Altamira Therapeutics Provides Business Update bit.ly/3R7zbdB
1
110
Altamira Therapeutics Announces Dissemination of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis Through Social Media Channels of Top Allergy Journal bit.ly/3wUFdav
1
2
153
Altamira Therapeutics Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal bit.ly/3QjjAHv
1
114